# IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma

> **NCT03407781** · PHASE1 · COMPLETED · sponsor: **Deling Li** · enrollment: 52 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** 68Ga-BBN-IRDye800CW

## Key facts

- **NCT ID:** NCT03407781
- **Lead sponsor:** Deling Li
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2018-08-17
- **Final completion:** 2018-08-17
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03407781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03407781, "IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03407781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*